Patents by Inventor Changfu Cheng

Changfu Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200330444
    Abstract: The invention provides novel chemical compounds useful for treating pain or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 22, 2020
    Inventors: Chaoran Huang, Changfu Cheng
  • Patent number: 10633367
    Abstract: Novel fluoride and/or deuterium-containing chemical, compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical compositions and methods of preparation and use thereof.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: April 28, 2020
    Assignee: X-CUTAG THERAPEUTICS, INC.
    Inventors: Changfu Cheng, Shuhao Wen, Hui Joyce Li
  • Patent number: 10519157
    Abstract: Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: December 31, 2019
    Assignee: X-CUTAG THERAPEUTICS, INC.
    Inventors: Hui Joyce Li, Shuhao Wen, Changfu Cheng, Xiao Chen, Gao Shang
  • Publication number: 20190248790
    Abstract: Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 15, 2019
    Applicant: X-Cutag Therapeutics, Inc.
    Inventors: Hui Joyce LI, Shuhao WEN, Changfu CHENG, Xiao CHEN, Gao SHANG
  • Publication number: 20190169171
    Abstract: Novel fluoride and/or deuterium-containing chemical, compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical compositions and methods of preparation and use thereof.
    Type: Application
    Filed: October 2, 2018
    Publication date: June 6, 2019
    Applicant: X-Cutag Therapeutics, Inc.
    Inventors: Changfu CHENG, Shuhao WEN, Hui Joyce LI
  • Patent number: 9968606
    Abstract: The invention provides novel chemical compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: May 15, 2018
    Assignee: NeuForm Pharmaceuticals, Inc.
    Inventors: Chaoran Huang, Changfu Cheng
  • Publication number: 20170368065
    Abstract: The invention provides novel chemical compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    Type: Application
    Filed: May 18, 2017
    Publication date: December 28, 2017
    Inventors: Chaoran Huang, Changfu Cheng
  • Patent number: 9688659
    Abstract: The invention provides novel chemical compounds useful for treating various hematologic malignancies, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: June 27, 2017
    Assignee: NeuForm Pharmaceuticals, Inc.
    Inventors: Chaoran Huang, Changfu Cheng
  • Publication number: 20170114041
    Abstract: The invention provides novel chemical compounds useful for treating various hematologic malignancies, or a related disease or disorder thereof, and pharmaceutical composition and methods of preparation and use thereof.
    Type: Application
    Filed: September 16, 2016
    Publication date: April 27, 2017
    Inventors: Chaoran Huang, Changfu Cheng
  • Publication number: 20140296263
    Abstract: The present invention in one embodiment relates to a compound of Formula (I); or a pharmaceutically acceptable salt thereof, wherein: each of R1 and R2 is independently selected from —CH3 and —CD3; R3 is hydrogen or deuterium; each of Z1, Z2 and Z3 is independently selected from hydrogen and deuterium; each Z4 is hydrogen or deuterium; each Z5 is hydrogen or deuterium; and each Z6 is hydrogen or deuterium.
    Type: Application
    Filed: July 19, 2012
    Publication date: October 2, 2014
    Applicant: CONCERT PHARMACEUTICALS, INC.
    Inventors: Ara Aslanian, Dolly Parasrampuria, Kristine Hogan, Virginia Braman, Changfu Cheng